Statin Use and Risk of Lymphoid Neoplasms: Results from the European Case-Control Study EPILYMPH

Abstract

Statin use was associated with an important reduction in lymphoma risk, adding to the growing evidence of anticancer properties of this group of drugs. These results are reassuring for the increasing number of patients taking statins on a regular basis.